• VUB and VIB construct a bio-incubator in the former Willy Van Der Meeren buildings

    Tuesday May 31st 2022

  • GSK to acquire clinical-stage biopharmaceutical company Affinivax, Inc.

    Tuesday May 31st 2022

  • argenx announces the UK MHRA has granted early access to efgartigimod for generalized myasthenia gravis

    Tuesday May 31st 2022

  • CureVac partners with myNEO to identify novel antigen targets for mRNA-based cancer vaccine development

    Wednesday May 25th 2022

  • Biotalys’ first biocontrol Evoca wins World BioProtection Award 2022 for Best Biofungicide Product

    Wednesday May 25th 2022

  • Latest field trials validate strength of Biotalys’ first biocontrol Evoca

    Thursday May 19th 2022

  • Belgian biotech in European Top-3 despite turbulent times

    Wednesday May 18th 2022

  • KU Leuven announces collaboration and license agreement with Gilead Sciences for the development of new antivirals against the respiratory syncytial virus

    Wednesday May 18th 2022

  • Your news here?

  • flanders.bio appoints CEO and COO in newly created role

    Wednesday May 18th 2022

  • Spearhead cluster flanders.healthTech turns into MEDVIA and is ready to make a change in healthcare innovation

    Tuesday May 17th 2022

  • QbD Group requalifies as Best Managed Company

    Friday May 13th 2022


Strategic Partners